FDMT

NASDAQStock

4D Molecular Therapeutics, Inc.

$8.35-0.10 (-1.24%)

52-Week Range

$2.51

$12.27

Key Stats

Market Cap

425.7M

P/E Ratio

—

Dividend Yield

—

Beta

3.01

Volume

308.2K

Avg Volume

761.1K

Performance

-9.63%

-22.83%

+26.31%

YTD

+15.44%

+102.15%

-53.98%

-82.65%

Price Chart

ETF Exposure

FDMT is held by 73 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VTI	Vanguard Total Stock Market ETF	0.00%	1,706,213	$15.1M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	8,974	$108K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	773	$9K	$1.29B	0.17%
AVUS	Avantis U.S. Equity ETF	0.00%	5,616	$42K	$10.96B	0.15%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	9,046	$76K	$40.55B	0.17%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	3	$28	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	11	$95	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	19	$161	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	22	$186	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	26	$220	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	22	$183	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	14	$121	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	11	$91	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	5	$40	$9.3M	0.12%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	1,085	$8K	$6.8M	0.60%
SCHB	Schwab U.S. Broad Market ETF	0.00%	20,000	$168K	$37.50B	0.03%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	1,085	$8K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	1,085	$8K	$1.0M	0.79%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	83	$1K	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,996	$36K	$12.17B	0.24%
VETS	Pacer Military Times Best Employers ETF	0.00%	1,085	$8K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	1,085	$8K	$3.7M	0.70%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	14	$173	$337.7M	0.32%

PreviousPage 2 of 2

About FDMT ETF Exposure

4D Molecular Therapeutics, Inc. (FDMT) is held by 73 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 425.7M, FDMT is a widely held institutional stock. The stock currently trades at $8.35. Investors can gain exposure to FDMT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold FDMT, sorted by portfolio weight.